CA Patent

CA3071096A1 — Co-administration of minocycline and colistin to reduce acute kidney injury

Assigned to Rempex Pharmaceuticals Inc · Expires 2018-07-12 · 8y expired

What this patent protects

Disclosed herein are methods of treating bacterial infection using a combination of minocycline and colistin to reduce the likelihood of acute kidney injury.

USPTO Abstract

Disclosed herein are methods of treating bacterial infection using a combination of minocycline and colistin to reduce the likelihood of acute kidney injury.

Drugs covered by this patent

Patent Metadata

Patent number
CA3071096A1
Jurisdiction
CA
Classification
—
Expires
2018-07-12
Drug substance claim
No
Drug product claim
No
Assignee
Rempex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.